UBS Group »

Immunome shares owned by UBS Group

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8M 584k 11.71
2025-06-30 $4.0M 426k 9.30
2025-03-31 $2.3M 344k 6.73
2024-12-31 $2.0M 188k 10.62
2024-09-30 $1.2M 79k 14.62
2024-06-30 $940k 78k 12.10
2024-03-31 $608k 25k 24.68
2023-09-30 $116 14 8.36
2023-06-30 $8.4k 1.1k 7.93
2023-03-31 $70 14 5.00
2022-12-31 $1.0k 474 2.21
2022-09-30 $0 15k 0.00
2022-06-30 $4.0k 1.3k 3.04
2022-03-31 $0 120 0.00
2021-12-31 $0 2.5k 0.00
2021-09-30 $0 14 0.00
2021-06-30 $24k 1.4k 17.52
2021-03-31 $15k 448 33.48
2020-12-31 $10k 1.0k 9.67